BRVE · Insider trading · 13F holders · Congress trades
Braveheart Bio, Inc. (BRVE)
Who is buying and selling BRVE: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 0
- Insider buys, 90 days
- $159.0M
- Insider sales, 90 days
- $0
- Congress trades, 12 months
- 0
BRVE at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 10 BRVE insiders filed 10 open-market purchases worth $159.0M on SEC Form 4.
- No 13F filer reports BRVE among its 50 largest positions.
- No member of Congress has disclosed a trade in BRVE.
- BRVE last closed at $21.19 on Oct 29, 2026.
BRVE insider trading
Between Aug 1, 2026 and Oct 29, 2026, 10 BRVE insiders filed 10 open-market purchases worth $159.0M on SEC Form 4.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | Chimovits Erez | Director, 10% Owner | Buy | 1,940,000 | $18.00 | $34.9M | SEC |
| Aug 11, 2026 | Orbimed Advisors LLC | Director, 10% Owner | Buy | 1,940,000 | $18.00 | $34.9M | SEC |
| Aug 11, 2026 | AH Bio Fund IV, L.P. | 10% Owner | Buy | 1,100,000 | $18.00 | $19.8M | SEC |
| Aug 7, 2026 | Forbion Growth Opportunities Fund III Cooperatief U.A. | 10% Owner | Buy | 3,600,000 | $18.00 | $64.8M | SEC |
| Aug 7, 2026 | Viehbacher Christopher | Director | Buy | 83,333 | $18.00 | $1.5M | SEC |
| Aug 7, 2026 | Murdoch Travis | CEO and President, Director | Buy | 83,333 | $18.00 | $1.5M | SEC |
| Aug 7, 2026 | Lubner David Charles | Director | Buy | 55,555 | $18.00 | $1000K | SEC |
| Aug 7, 2026 | Rickey James Paul | Chief Financial Officer | Buy | 27,777 | $18.00 | $500K | SEC |
| Aug 7, 2026 | Malek David I | Director | Buy | 4,166 | $18.00 | $75K | SEC |
| Aug 7, 2026 | Anderson Michele A. | Chief Development Officer | Buy | 1,111 | $18.00 | $20K | SEC |
Who owns BRVE? Hedge funds and superinvestors
No 13F filer reports BRVE among its 50 largest positions.
BRVE stock trades by members of Congress
No member of Congress has disclosed a trade in BRVE.
Analysis mentioning BRVE
Posts from the blog that cover Braveheart Bio, Inc., newest first.
BRVE questions and answers
Are insiders buying BRVE stock?
Between Aug 1, 2026 and Oct 29, 2026, 10 BRVE insiders filed 10 open-market purchases worth $159.0M on SEC Form 4.
Which hedge funds own BRVE?
No 13F filer reports BRVE among its 50 largest positions.
Has Congress traded BRVE?
No member of Congress has disclosed a trade in BRVE.
Cite or share this
Free to use with a link back. The data updates every filing day.